Effects of Ganoderma lucidum on chemical-induced and bacterial-infected corneal ulceration of rabbits’ eyes
Open Access
- 16 February 2023
- journal article
- research article
- Published by F1000 Research Ltd in F1000Research
- Vol. 12, 185
Abstract
Background: Corneal ulcerations pose risks to blindness, and their treatment presents huge challenges, in part due to increased resistance to anti-bacterial drugs, accessibility and cost issues, particularly in developing countries. This study investigated the pharmacological effect of Ganoderma Lucidum, on chemical-induced and bacterial-infected corneal ulceration of rabbits’ eyes. Methods: This was a randomized-controlled experiment of 16 healthy New Zealand rabbits, randomly assigned into four groups (A–D). The right eye cornea was injured using a drop of 1 Molar sodium hydroxide and followed by infection with Pseudomonas aeruginosa after 12 hours, in all groups except group A. Treatment with freshly prepared crude aqueous extract of G. lucidum (40 μg/mL) for groups A and B, the standard treatment protocol for group C, and atropine alone for group D commenced after 24 hours and continued every four hours for seven days. All data collected, pre-and post-tests, were analysed at α=0.05 using Wilcoxon signed-rank test for correlated variables and the Mann–Whitney U test for independent variables. Results: G. lucidum has significant clinical effects (74%) on corneal injury and ulcers (92%). The healing effects observed at the 168th hour were significantly better than those observed at the 24th hour (p0.05), the mean effect size was clinically significant (31%). Conclusion: This study demonstrates the potential antimicrobial potential of G. lucidum. G. lucidum may provide an alternative treatment option for chemical-induced and bacterial-infected corneal ulcers, particularly in resource-constrained countries.Keywords
This publication has 11 references indexed in Scilit:
- Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbiditiesOsteoarthritis and Cartilage, 2016
- Spread of Multidrug-Resistant Pseudomonas aeruginosa Clones in a University HospitalJournal of Clinical Microbiology, 2013
- Ocular chemical injuries and their managementOman Journal of Ophthalmology, 2013
- Management of ocular thermal and chemical injuries, including amniotic membrane therapyCurrent Opinion in Ophthalmology, 2010
- Ganoderma lucidum: A Potent Pharmacological MacrofungusCurrent Pharmaceutical Biotechnology, 2009
- Ganodermataceae: Natural Products and Their Related Pharmacological FunctionsThe American Journal of Chinese Medicine, 2007
- Infection control and quality health care in the new milleniumAmerican Journal of Infection Control, 2005
- Targets and assays for discovering novel antibacterial agentsJournal of Biotechnology, 2002
- A Phase I/II Study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. Extract (Ganopofy) in Patients with Advanced CancerInternational Journal of Medicinal Mushrooms, 2002
- GUIDELINES FOR ETHICAL CONDUCT IN THE CARE AND USE OF ANIMALS1Journal of the Experimental Analysis of Behavior, 1986